Background and aim: Although there is a growing interest on the use of non-heart beating donors to enlarge the liver donor pool, livers with prolonged warm ischaemia time are not currently considered for organ transplantation. We hypothesised that these organs may represent a source of hepatocytes for cell transplantation and/or use in bioartificial liver devices. Thus, we investigated if prolonged ischaemia could influence the recovery and viability of functional hepatocytes dissociated from rat livers. Methods: Hepatocytes were isolated from the liver within 15 min after death (t = 15 min) and after 4, 8 and 12 h of ischaemia. Cells were either maintained in culture or cryopreserved. In all products, we evaluated cell recovery and viabili...
Objective: Hepatocyte transplantation is a potential alternative to liver replacement in humans. Sev...
[Background]: Ischemia-reperfusion (I/R) injury associated with hepatic resections and liver transpl...
Liver transplantation is currently the preferred treatment option for end-stage liver disease. Donat...
Successful cryopreservation of human hepatocytes is important to establish hepatocyte banks for clin...
Introduction, Clinical bioartificial liver development for the treatment of liver failure has been a...
The aim of this thesis was to assess feasibility of using chronically injured liver as a source for ...
Hepatocyte transplantation is emerging as an additional modality of treatment for patients with acut...
Background/Aims: Suspensions of isolated hepatocytes are a valuable tool to study liver functions, F...
Isolated human primary hepatocytes are an essential in vitro model for basic and clinical research. ...
Abstract: Background: The availability of well-characterized human liver cell populations that can b...
Human hepatocyte transplantation is an alternative treatment for acute liver failure and liver disea...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Liver transplantation is a highly efficacious intervention for end stage liver failure. Unfortunatel...
BACKGROUND: Non-heart-beating donor (NHBD) livers represent an important organ pool, but are seldom ...
Abstract: The aim of this thesis was to assess feasibility of using chronically injured liver as a s...
Objective: Hepatocyte transplantation is a potential alternative to liver replacement in humans. Sev...
[Background]: Ischemia-reperfusion (I/R) injury associated with hepatic resections and liver transpl...
Liver transplantation is currently the preferred treatment option for end-stage liver disease. Donat...
Successful cryopreservation of human hepatocytes is important to establish hepatocyte banks for clin...
Introduction, Clinical bioartificial liver development for the treatment of liver failure has been a...
The aim of this thesis was to assess feasibility of using chronically injured liver as a source for ...
Hepatocyte transplantation is emerging as an additional modality of treatment for patients with acut...
Background/Aims: Suspensions of isolated hepatocytes are a valuable tool to study liver functions, F...
Isolated human primary hepatocytes are an essential in vitro model for basic and clinical research. ...
Abstract: Background: The availability of well-characterized human liver cell populations that can b...
Human hepatocyte transplantation is an alternative treatment for acute liver failure and liver disea...
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the ...
Liver transplantation is a highly efficacious intervention for end stage liver failure. Unfortunatel...
BACKGROUND: Non-heart-beating donor (NHBD) livers represent an important organ pool, but are seldom ...
Abstract: The aim of this thesis was to assess feasibility of using chronically injured liver as a s...
Objective: Hepatocyte transplantation is a potential alternative to liver replacement in humans. Sev...
[Background]: Ischemia-reperfusion (I/R) injury associated with hepatic resections and liver transpl...
Liver transplantation is currently the preferred treatment option for end-stage liver disease. Donat...